Skip to main content
Premium Trial:

Request an Annual Quote

Ludwig Cancer Institute Expands Cancer Gene-Expression Collab With Lynx

NEW YORK, Nov. 12 - Lynx Therapeutics today said the Ludwig Institute for Cancer Research has asked it to extend a cancer gene-expression collaboration begun in July that relies on the company's MPSS technology.

 

Terms of the agreement calls for an undisclosed number of LICR branches worldwide to send tissue samples to Lynx for gene-expression studies. Data from this expanded partnership will be "compatible" with gene-expression information that Lynx generated for the National Cancer Institute, the company added.

 

"The data should allow us to do a lot more than we ever could before with microarrays, SAGE, and ESTs," Andrew Simpson, a senior geneticist with LICR, said in a statement. "We plan to do many more MPSS analyses as soon as possible."

 

Click here for more information.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.